Efficacy and safety of Privigen ® in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label Phase III study (the PRIMA study)
Léger, Jean-Marc, De Bleecker, Jan L., Sommer, Claudia, Robberecht, Wim, Saarela, Mika, Kamienowski, Jerzy, Stelmasiak, Zbigniew, Mielke, Orell, Tackenberg, Björn, Shebl, Amgad, Bauhofer, Artur, ZenkeVolume:
18
Language:
english
Journal:
Journal of the Peripheral Nervous System
DOI:
10.1111/jns5.12017
Date:
June, 2013
File:
PDF, 717 KB
english, 2013